EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy and Safety of Intralesional Vitamin D3 in Treatment of Viral Warts: A Systematic Review and Meta-analysis

Ahmad A. El-Ebiary, Ahmed A. Alsaati

Journal of Dermatology and Dermatologic Surgery · 2025-07 · 29 (2) · 77-88

DOI: 10.4103/jdds.jdds_35_24 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Dermatology and Dermatologic Surgery, online erschienen am 09.04.2026. Verfasst von Ahmad A. El-Ebiary und 1 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intralesional Vitamin D3 has recently demonstrated encouraging outcomes in the treatment of various wart types.

Purpose

This study evaluated the efficacy and safety of intralesional Vitamin D3 in the treatment of viral warts.

Methods

We included randomized controlled trials that reported the efficacy of intralesional Vitamin D3 in the treatment of warts.

Results

Twenty-eight studies with a total of 1983 patients were included. For all types of warts, intralesional Vitamin D3 was more effective than placebo (risk ratio [RR] = 6.44; 95% confidence interval [CI]: 2.58–16.10, P < 0.0001), Candida antigen (Ag) (RR = 1.14; 95% CI: 0.76–1.71, P = 0.54), and cryotherapy (RR = 1.52; 95% CI: 1.18–1.95, P = 0.01) in achieving complete clearance of warts at site of injection. Vitamin D3 was less effective than purified protein derivative (PPD) (RR = 0.90; 95% CI: 0.76–1.05, P = 0.18), measles, mumps, and rubella (MMR) (RR = 0.89; 95% CI: 0.76–1.05, P = 0.18), and Bacillus Calmette–Guérin (BCG) (RR = 0.69; 95% CI: 0.53–0.90, P = 0.005). In patients with plantar warts, intralesional Vitamin D3 was more effective than Candida Ag (RR = 1.44; 95% CI: 0.87–2.36, P = 0.15), zinc sulfate 2% (RR = 1.20; 95% CI: 0.81–1.77, P = 0.36), and placebo (RR = 4.87; 95% CI: 1.43–16.63, P = 0.01). For common warts, Vitamin D3 was more effective than placebo (RR = 8.25; 95% CI: 1.65–41.29, P = 0.01). Vitamin D3 also cleared more distant warts than did placebo (RR = 11.83; 95% CI: 3.39–41.26, P = 0.0001) and zinc sulfate 2% (RR = 2.50; 95% CI: 0.06–105.62, P = 0.63). Efficacy of Vitamin D3 in achieving complete cure at distant sites was lower than for Candida Ag (RR = 0.56; 95% CI: 0.20–1.57, P = 0.27) and PPD (RR = 0.93; 95% CI: 0.69–1.25, P = 0.63). Most of the adverse effects associated with Vitamin D3 were not severe. Vitamin D3 had lower recurrences than Candida Ag, MMR, zinc sulfate 2%, and placebo, while PPD showed better results than Vitamin D3.

Conclusion

Intralesional Vitamin D3 is an effective and tolerable immunotherapeutic agent for wart treatment.

Zitieren

APA

El-Ebiary, A. A., & Alsaati, A. A. (2025). Efficacy and Safety of Intralesional Vitamin D3 in Treatment of Viral Warts: A Systematic Review and Meta-analysis. Journal of Dermatology and Dermatologic Surgery, 29(2), 77-88. https://doi.org/10.4103/jdds.jdds_35_24

Vancouver

El-Ebiary AA, Alsaati AA. Efficacy and Safety of Intralesional Vitamin D3 in Treatment of Viral Warts: A Systematic Review and Meta-analysis. Journal of Dermatology and Dermatologic Surgery. 2025;29(2):77-88. doi:10.4103/jdds.jdds_35_24

BibTeX
@article{ElEbiary2025,
  author = {El-Ebiary, Ahmad A. and Alsaati, Ahmed A.},
  title = {Efficacy and Safety of Intralesional Vitamin D3 in Treatment of Viral Warts: A Systematic Review and Meta-analysis},
  journal = {Journal of Dermatology and Dermatologic Surgery},
  year = {2025},
  volume = {29},
  number = {2},
  pages = {77--88},
  doi = {10.4103/jdds.jdds_35_24}
}
Kostenlos starten →